Sivik Global Healthcare LLC Reduces Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Sivik Global Healthcare LLC reduced its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 56.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 50,000 shares of the company’s stock after selling 65,000 shares during the period. Sivik Global Healthcare LLC’s holdings in Acadia Healthcare were worth $1,983,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of ACHC. State Street Corp boosted its stake in Acadia Healthcare by 3.5% in the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after acquiring an additional 95,613 shares during the period. JPMorgan Chase & Co. grew its holdings in Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after buying an additional 454,044 shares in the last quarter. LMR Partners LLP bought a new stake in Acadia Healthcare during the 3rd quarter valued at $1,616,000. SG Americas Securities LLC boosted its position in Acadia Healthcare by 713.3% during the 4th quarter. SG Americas Securities LLC now owns 110,866 shares of the company’s stock worth $4,396,000 after acquiring an additional 97,235 shares during the period. Finally, Principal Financial Group Inc. grew its stake in shares of Acadia Healthcare by 2.1% in the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock worth $41,653,000 after purchasing an additional 13,368 shares in the last quarter.

Acadia Healthcare Price Performance

ACHC opened at $44.20 on Thursday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a 1 year low of $36.50 and a 1 year high of $87.77. The stock has a fifty day moving average price of $41.53 and a 200 day moving average price of $55.91. The stock has a market cap of $4.11 billion, a price-to-earnings ratio of 14.49, a PEG ratio of 1.79 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same quarter last year, the firm earned $0.91 earnings per share. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. Analysts forecast that Acadia Healthcare Company, Inc. will post 3.39 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 price target on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Royal Bank of Canada reiterated an “outperform” rating and set a $64.00 price objective on shares of Acadia Healthcare in a research note on Friday, January 10th. TD Cowen cut their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. Finally, Barclays cut their price objective on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $70.22.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.